Erythrokeratodermia Variabilis: a Report of a Tunisian Case

Erythrokeratodermia Variabilis: a Report of a Tunisian Case

GENETICS AND GENODERMATOSES ERYTHROKERATODERMIA VARIABILIS: A REPORT OF A TUNISIAN CASE S Gara (1) - R Bribech (1) - T Bacha (1) - A Toumi (1) - M Jones (1) - F Zeglaoui (1) Charles Nicolle Hospital, Dermatology, Tunis, Tunisia (1) Background: Erythrokeratodermia variabilis and prgressiva (EKVP) is a rare genodermatosis, predominantly inherited in an autosomal dominant mode. It is characterized by two morphologic clinical features: fixed hyperkeratotic plaques and transient erythematous patches. Literature data reported very few cases of EKVP in north Africa. We present herein a sporadic case of EKVP in a four-year-old tunisian boy. Observation: A four-year-old boy with no past medical history was referred to our department for evaluation of skin lesions. He was born to non-consanguineous unaffected parents. Lesions appeared four months ago and progressively enlarged. Dermatological examination revealed multiple, hyperkeratotic, brownish plaques, well demarcated, with geographic borders, variable in size and shape. These lesions were fixed and symmetrically distributed on elbows, the perineal region and the back of the thighs. There was not palmoplantar keratoderma. The clinical lesions were suggestive of EKVP. A cutaneous biopsy was performed. The histopathologic examination revealed orthokeratotic hyperkeratosis and papillomatosis, with a church spire configuration of the epidermis. The dermis was unchanged. The patient’s skin had been normal at birth. The clinical and histopathological findings were consistent with the diagnosis of EKV. The patient showed a partial improvement under topical treatment with keratolytic agents. Key message: EKVP is a rare inherited disorder of keratinization. The diagnosis is usually missed. Cutaneous lesions are heterogeneous and include migratory patches and fixed hyperkeratotic plaques. Treatment is only symptomatic. It usually involves the use of topical keratolytic agents and emollient. Low dose systemic retinoid may be beneficial in severe cases. Powered by TCPDF (www.tcpdf.org).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us